Higher potency of N-(4-hydroxyphenyl)retinamide than all-transretinoic acid in induction of apoptosis in non-small cell lung cancer cell lines

Clinical Cancer Research

Volumn 4, Issue 5, 1998, Pages 1345-1355

  Zou, Chang Ping ^a   Kurie, Jonathan M ^a   Lotan, Dafna ^a   Zou, Chang Chun ^a   Hong, Waun Ki ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; FENRETINIDE; MESSENGER RNA; PROTEIN BCL 2; PROTEIN P53; RETINOIC ACID;

ADENOSQUAMOUS CARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL CYCLE; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; FENRETINIDE; GENES, BCL-2; HUMANS; LUNG NEOPLASMS; RECEPTORS, RETINOIC ACID; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031924606     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer Statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Mountain, C. F. A new international staging for lung cancer. Chest, 89: 225s-233s, 1986.
3. Gazdar, A. F. The molecular and cellular basis of human lung cancer. Anticancer Res., 13: 261-268, 1994.
4. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
5. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunhill, M. S., Pierce, C. B., Gatter, K. C., and Mason, Y. Bcl-2 protein in non-small cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
6. Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D., D'Amico, D., Bonder, S., Oie, H, K., Linnoila, R. I., Mulshine, J. L., Minna, J. D., and Gazdar, A. F. p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7: 171-180, 1992.
7. Ohsaki, Y., Toyoshima, E., Fujiuchi, S., Matsui H., Hirata S., Miyokawa, N., Kubo, Y., and Kikuchi, K. Bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin. Cancer Res., 2: 915-920, 1996.
8. Wang, Y., Szekely, L., Okan, I., Klein, G., and Wiman, K. G. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-mvcinduced T-cell lymphoma line. Oncogene, 8: 3427-3431, 1993.
9. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
10. Dole, M., Nunez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A., and Castle, V. P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res., 54: 3253-3259, 1994.
11. Wolbach, S. B., and Howe, P. R. Tissue changes following deprivation of fat-soluble A-vitamin. J. Exp. Med., 42: 753-778, 1925.
12. Auerbach, O., Stout, A. P., Hammond, E. C., and Garfinkel, L. Bronchial epithelium in former smokers. N. Engl. J. Med., 267: 119-125, 1962.
13. Graham, S. Epidemiology of retinoids and cancer. J. Natl. Cancer Inst., 73: 1423-1428, 1984.
14. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: H. M. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 597-658. New York: Raven Press, 1994.
15. Sporn, M. B., and Newton, D. L. Chemoprevention of cancer with retinoids. Fed. Proc., 38: 2528-2534, 1979.
16. Moon, R. C., Mehta, R. G., and Rao, K. J. V. N. Retinoids and cancer in experimental animals. In: H. M. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 573-595. New York: Raven Press, 1994.
17. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Pirket, P., Buyse, Rosementz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P. A., and Ravasi, G. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J. Clin. Oncol., 11: 1216-1222, 1993.
18. Harris, C. C, Silverman, T., Smith, J. M., Jackson, F., and Boren, H. G. Proliferation of tracheal epithelial cells in normal and vitamin A-deficient Syrian golden hamsters. J. Natl. Cancer Inst., 51: 1059-1062, 1973.
19. Jetten, A. M. Multistep process of squamous differentiation in tracheobronchial epithelia cells in vitro: analogy with epidermal differentiation. Environ. Health Perspect., 80: 149-160, 1989.
20. Jetten, A. M., Nervi, C., and Vollberg, T. M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr., 13: 93-100, 1992.
21. Gebert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J., and Neel, B. G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene, 6: 1859-1868, 1991.
22. Houle, B., Leduc, F., and Bradley, W. E. Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer, 3: 358-366, 1991.
23. Nervi, C., Vollberg, T. M., George, M. D., Chambon, P., and Jetten, A. M. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp. Cell Res., 195: 163-170, 1991.
24. Geradts, J., Chen, J-Y., Russell, E. K., Yankaskas, J. R., Nieves, L., and Minna, J. D. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ., 4: 799-809, 1993.
25. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
26. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: H. M. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 319-349. New York: Raven Press, 1994.
27. Ahn, M. J., Langenfeld, J., Moasser, M. M., Rusch, V., and Dmitrovsky, E. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. Oncogene, 11: 2357-2364, 1995.
28. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocrinol. Rev., 14: 651-658, 1992.
29. Kim, Y. H., Dohi, D. F., Han, H., Zou, C-P., Oridate, N., Garrett, L., Nesbitt, J. C., Xu, X-C., Hong, W. K., Lotan, R., and Kurie, J. M. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
30. Xu, X-C., Sozzi, G., Lee, J. S., Lee, J. J., Pastorino, U., Pilotti, S., Kurie, J. M., Hong, W. K., and Lotan, R. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J. Natl. Cancer Inst., 89: 624-629, 1997.
31. Zhang, X. K., Liu, Y., Lee, M-O., and Pfahl, M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res., 54: 5663-5669, 1994.
32. Moghal, N., and Neel, B. G. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol., 15: 3945-3959, 1995.
33. Grunberg, S., and Itri, L. Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer. Cancer Treat. Rep., 71: 1097-1098, 1987.
34. Treat, J., Friedl, D., Luginbuhl, W., Meehan, L., Gorman, G., Miller, W., Bavaria, J., and Kaiser, L. Phase II trial of all-trans-retinoic acid in metastatic non-small cell lung cancer. Cancer Invest., 14: 415-420, 1996.
35. Lotan, R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst., 87: 1655-1657, 1995.
36. Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistosi, V., Raffaghello, L., Rozzo, C., and Montaldo, P. G. Differential effects of N-(4-hydroxyphenyl) retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res., 55: 853-861, 1995.
37. Mariotti, A., Marcora, E., Bunone, G., Veronesi, U., Pierotti, M. A., and Valle, G. D. N-(4-hydroxyphenyl) retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst., 86: 1245-1247, 1994.
38. Delia, D., Aiello, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J. C., and Pierotti, M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated Bcl-2. Blood, 85: 359-367, 1995.
39. Oridate, N., Lotan, D., Xu, X-C., Hong, W. K., and Lotan, R. Differential induction of apoptosis by all-trans retinoic acid and N-(4-hydroxyphenyl) retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
40. Oridate, N., Lotan, D., Mitchell, M., Hong, W. K., and Lotan, R. Induction of apoptosis by retinoids in human cervical carcinoma cell lines. Int. J. Oncol., 7: 433-441, 1995.
41. Kalemkerian, G. P., Slusher, R., Ramalingam, S., Gadgeel, S., and Mabry, M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J. Natl. Cancer Inst., 87: 1674-1680, 1995.
42. Phelps, R. M., Johnson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R, Linnoila, I. L., Mattews, M. J., Bunn, P. A., Jr., Carney, D., Minna, J. D., and Mulshine, J. NCI-Navy medical oncology branch cell line data base. J. Cell Biochem., 24: 32-91, 1989.
43. Kueng, W., Silber, E., and Eppenberger, U. Quantification of cells cultured on 96-well plates. Anal. Biochem., 182: 16-19, 1989.
44. Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C., and Raff, M. C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.), 36: 365-369, 1993.
45. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
46. Chirgwin, J. M., Pryzbyla, A. E., MacDonald, G. R., Walsh, G. L., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
47. Brand, N., Petkovitch, Krust A., Chambon, P., de The, H., Marchio, M., Tiollais, P., and Dejean, A. Identification of a second human retinoic acid receptor. Nature (Lond.), 332: 850-853, 1988.
48. Dugaiczyk, A., Haron, J. A., Stone, E. M., Dennison, O. E., Rothblum, K. N., and Swartz, R. J. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry, 22: 1605-1613, 1983.
49. Ferrari, N., Pfeffer, U., Tosetti, F., Brigati, C., and Vidali, G. An improved RT-PCR protocol for the quantitation of human retinoic acid receptor RNA. Exp. Cell Res., 211: 121-126, 1994.
50. Zou, C-P., Clifford, J., Xu, X-C., Sacks, P., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck carcinoma cells lines. Cancer Res., 54: 5479-5487, 1994.
51. Li, X. S., Shao, Z. M., Sheikh, M. S., Eiseman, J. L., Sentz, D., Jetten, A. M., Chen, J. C., Dawson, M. I., Aisner, S., Rishi, A. K., Gutierrez, P., Schnapper, L., and Fontana, J. A. Retinoic aid nuclear receptor β inhibits breast carcinoma anchorage-independent growth. J. Cell Physiol., 165: 449-458, 1995.
52. Si, S. P., Lee, X. L., Tsou, H. C., Buchsbaum, R., Tibaduiza, E., and Peacocke, M. RARβ2-mediated growth inhibition in HeLa cells. Exp. Cell Res., 223: 102-111, 1996.
53. Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. Expression of RARβ mediates RA-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ., 6: 1077-1088, 1995.
54. Liu, Y., Lee, M. O., Wang, H. G., Li, Y., Hashimoto, Y., Klaus, M., Reed., J. C., and Zhang., X. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
55. Zhang, X-K., Liu, Y., and Lee, M-O. Retinoid receptors in human lung cancer and breast cancer. Mutat. Res., 350: 267-277, 1996.
56. Oren, M., Reich, N. C., and Levine, A. J. Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol. Cell. Biol., 2: 443-449, 1982.
57. Davidoff, A. M., Pence, J. C., Shorter, N. A., Igelhart, J. D., and Marks, J. R. Expression of p53 in human neuroblastoma-and neuroepithelioma-derived cell lines. Oncogene, 7: 127-133, 1992.
58. Lutzker, S. G., and Levine, A. J. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med., 2: 804-810, 1996.
59. Maxwell, S. A., and Mukhopadhyay, T. Transient stabilization of p53 in non-small cell lung carcinoma cultures arrested for growth by retinoic acid. Exp. Cell Res., 214: 67-74, 1994.
60. Benito, A., Grillot, D., Nunez, G., and Fernandez-Luna, J. S. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am. J. Pathol., 146: 481-490, 1995.
61. Nagy, L., Thomazy, V. A., Chandraratna, R. A. S., Heyman, R. A., and Davies, P. J. A. Retinoid-regulated expression of Bcl-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leuk. Res., 20: 499-505, 1996.
62. Okazawa, H., Shimizu, J., Kamei, M., Imafuku, I., Hamada, H., and Kanazawa, I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal carcinoma stem cells. J. Cell Biol., 132: 955-968, 1996.
63. Dipietrantonio, A., Hsieh, T-C., and Wu, J. M. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl)retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells. Biochem. Biophys Res. Commun., 224: 837-842, 1996.
64. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
65. Thompson, H. J., Strange, R., and Schedin, P. J. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol. Biomarkers Prev., 1: 597-602, 1992.
66. Dive, C., and Wyllie, A. H. Apoptosis and cancer chemotherapy. In: J. A. Hickman and T. T. Tritton (eds.), Frontiers in Pharmacology: Cancer Chemotherapy, pp. 21-56. Oxford: Blackwell Scientific Publications, Ltd., 1993.
67. Lotan, R. Cellular biology of the retinoids. In: L. Degos and D. R. Parkinson (eds.), Retinoids in Oncology, pp. 27-42. Berlin: Springer-Verlag, 1995.
68. Kochhar, D. M., Jiang, H., Harnish, D. C., and Soprano, D. R. Evidence that retinoic acid-induced apoptosis in the mouse limb bud core mesenchymal cells is gene-mediated. Prog. Clin. Biol. Res., 383B: 815-825, 1993.
69. Formelli, F., Clerici, M., Campa, T., Mauro, M. G., Magni, A., Mascotti, G, Moglia, D., De Palo, G., Costa, A., and Veronesi, U. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol., 11: 2036-2042, 1993.
70. Berard, J., Laboune, F., Mukuna, M., Masse, S., Kothary, R., and Bradley, W. E. C. Lung tumors in mice expressing an anti-sense RARβ2 transgene. FASEB J., 10: 1091-1097, 1996.
71. Houle, B., Rochette-Egly, C., and Bradley, W. E. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA, 90: 985-989, 1993.
72. de The, H., Vivanco-Ruiz, M. M., Tiollais, P., and Dejean, A. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature (Lond.), 343: 177-180, 1990.
73. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ., 5: 133-141, 1994.
74. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
75. Canman, C., Gilmer, T., Coutts, S., and Kastan, M. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9: 600-611, 1995.
76. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
77. Oridate, N., Suzuki, S., Higuchi, M., Mitchell, M. F., Hong, W. K., and Lotan, R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J. Natl. Cancer Inst., 89: 1191-1198, 1997.
78. Kelloff, G. J., and the National Cancer Institute Division of Cancer Prevention and Control Chemoprevention Branch and Agent Development Committee. Clinical development plan: N-(4-hydroxyphenyl)retinamide. J. Cell. Biochem., 20 (Suppl.): 176-196, 1994.
79. Formelli, F., Barua, A. B., and Olson, J. A. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl β-glucuronide. FASEB J., 10: 1014-1024, 1996.